Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling

Topic: Brain imaging, connectivity and assessment

Alzheimer's Disease (AD) is characterized by a cascade of biomarkers becoming abnormal, the pathophysiology of which is very complex and largely unknown. Event-based modeling (EBM) is a data-driven technique to estimate the sequence in which biomarkers for a disease become abnormal based on cross-sectional data. It can help in understanding the dynamics of disease progression and facilitate early diagnosis and prognosis by staging patients. In this work we propose a novel discriminative approach to EBM, which is shown to be more accurate than existing state-of-the-art EBM methods. The method first estimates for each subject an approximate ordering of events. Subsequently, the central ordering over all subjects is estimated by fitting a generalized Mallows model to these approximate subject-specific orderings based on a novel probabilistic Kendall's Tau distance. We also introduce the concept of relative distance between events which helps in creating a disease progression timeline. Subsequently, we propose a method to stage subjects by placing them on the estimated disease progression timeline. We evaluated the proposed method on Alzheimer's Disease Neuroimaging Initiative (ADNI) data and compared the results with existing state-of-the-art EBM methods. We also performed extensive experiments on synthetic data simulating the progression of Alzheimer's disease. The event orderings obtained on ADNI data seem plausible and are in agreement with the current understanding of progression of AD. The proposed patient staging algorithm performed consistently better than that of state-of-the-art EBM methods. Event orderings obtained in simulation experiments were more accurate than those of other EBM methods and the estimated disease progression timeline was observed to correlate with the timeline of actual disease progression. The results of these experiments are encouraging and suggest that discriminative EBM is a promising approach to disease progression modeling.

Key findings

• We evaluated the proposed method on Alzheimer's Disease Neuroimaging Initiative (ADNI) data and compared the results with existing state-of-the-art EBM methods.
• The results of these experiments are encouraging and suggest that discriminative EBM is a promising approach to disease progression modeling.

New to this subject? Start with our plain-English guide: Digital health →

Study details

• Study designcross-sectional
• Evidence strengthLow

Read the original

• DOI: 10.1016/j.neuroimage.2018.11.024
• PubMed: 30471388
• Original source →

Free copy unknown: no free-copy check has an answer for this record yet. That does not mean it is paywalled.

@article{venkatraghavan2019-30471388,
  author  = {Venkatraghavan, V. and Bron, E. E. and Niessen, W. J. and Klein, S. and {Alzheimer's Disease Neuroimaging Initiative}},
  title   = {{Disease progression timeline estimation for Alzheimer's disease using discriminative event based modeling}},
  journal = {NeuroImage},
  year    = {2019},
  doi     = {10.1016/j.neuroimage.2018.11.024},
  pmid    = {30471388},
  url     = {https://doi.org/10.1016/j.neuroimage.2018.11.024}
}

Related studies in Digital health tools

• Machine learning for modeling the progression of Alzheimer disease dementia using clinical data: a systematic literature review JAMIA open · 2021-07-01 · usefulness score 44/100
• Characterizing the Clinical Features and Atrophy Patterns of MAPT-Related Frontotemporal Dementia With Disease Progression Modeling Neurology · 2021-06-22 · usefulness score 61/100
• Estimation of Machine Learning–Based Models to Predict Dementia Risk in Patients With Atherosclerotic Cardiovascular Diseases: UK Biobank Study JMIR Aging · 2025-01-20 · usefulness score 46/100
• Gait and movement analysis for discrimination between people with dementia and healthy control persons based on pose estimation and machine learning Journal of Alzheimer s Disease · 2026-03-15 · usefulness score 43/100
• Electroencephalogram and Event-Related Potential in Mild Cognitive Impairment: Recent Developments in Signal Processing, Machine Learning, and Deep Learning IEEE Journal of Selected Areas in Sensors · 2025-01-01 · usefulness score 43/100
• Predicting the progression of mild cognitive impairment using machine learning: A systematic, quantitative and critical review Medical image analysis · 2020-10-06 · usefulness score 70/100

Similar studies

• FastEBM: Fast, Scalable, and Uncertainty-Aware Event-Based Disease Progression Modeling 2026 · Brain scans and imaging
• Interpretable Phenotype Discovery Using Temporal Risk-Aware Clustering 2026 · Long-term cohort studies
• Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer's disease 2023 · Tau biomarkers
• Biomarker Variability Limits Individualized Amyloid Time Estimation in Alzheimer Disease 2026 · Brain scans and imaging
• Accurate multimodal probabilistic prediction of conversion to Alzheimer's disease in patients with mild cognitive impairment 2013 · Digital health tools
• Tau-CTFP: A connectome-informed continuous-time first-passage model for forecasting the onset of regional tau PET abnormality 2026 · Brain scans and imaging

More on Digital health tools

• A review that covers this ground Machine learning methods for predicting progression from mild cognitive impairment to Alzheimer's disease dementia: a systematic review Alzheimer's research & therapy · 2021-09-28 · usefulness score 65/100
• Newest in this subject Speaker-Wise Dementia Screening fromNaturalistic Speech with Lexical Entropy, Semantic Drift, and Multimodal Fusion Research Square · 2026-10-21 · Preprint — not yet peer-reviewed · usefulness score 16/100
• Newest in this subject Integrating Multisource Target Evidence with Machine-Learning Potency Prediction for Alzheimer’s Disease Drug Discovery bioRxiv · 2026-10-20 · Preprint — not yet peer-reviewed · usefulness score 16/100

See all studies in Digital health tools →